Nephrotic syndrome diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
'''Relative contrandications of the kidney biopsy:''' | '''Relative contrandications of the kidney biopsy:''' | ||
*Single kidney | *Single kidney, | ||
*Anatomic kidney abnormalities | *Anatomic kidney abnormalities, | ||
* Small size [[kidneys]] (less than 9 cm), indicative of [[end stage renal disease]] | * Small size [[kidneys]] (less than 9 cm), indicative of [[end stage renal disease]] | ||
* Renal tumor | * Renal tumor | ||
Revision as of 20:23, 5 June 2018
|
Nephrotic Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Nephrotic syndrome diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Nephrotic syndrome diagnostic study of choice |
|
Risk calculators and risk factors for Nephrotic syndrome diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Diagnostic study of choice for nephrotic syndrome is kidney biopsy that reveals the exact type of disease and the its progression.
Diagnostic Study of Choice
Study of choice
- Kidney biopsy is the gold standard test for the diagnosis of nephrotic syndrome.[1]
- This method will reveal the exact cause of proteinuria.
Relative contrandications of the kidney biopsy:
- Single kidney,
- Anatomic kidney abnormalities,
- Small size kidneys (less than 9 cm), indicative of end stage renal disease
- Renal tumor
- Multiple, bilateral cysts
- Active infection in the kidney or on the skin over the biopsy side
- Uncorrectable bleeding diathesis
- Severe uncontrolled hypertension
- Hydronephrosis
- Uncooperative patient